BIIB vs GIS · P/E 21, rev $9.89B vs P/E 8.2, rev $18.42B
Biogen Inc (BIIB) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the BIIB and GIS stock pages for the full models.
Not investment advice.